{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:40:29Z","timestamp":1792525229546,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s12149-026-02258-1","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T07:58:03Z","timestamp":1784879883000},"page":"1415-1424","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of a machine learning-based hierarchical classification model for predicting the early therapeutic response to initial 131I therapy in papillary thyroid carcinoma"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2644-0571","authenticated-orcid":false,"given":"Zhiyue","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"1","key":"2258_CR1","first-page":"47","volume":"4","author":"B Han","year":"2024","unstructured":"Han B, Zheng R, Zeng H, Wang S, Sun K, Chen R, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent. 2024;4(1):47\u201353.","journal-title":"J Natl Cancer Cent"},{"issue":"10387","key":"2258_CR2","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","volume":"401","author":"DW Chen","year":"2023","unstructured":"Chen DW, Lang BHH, McLeod DSA, Newbold K, Haymart MR. Thyroid cancer. Lancet. 2023;401(10387):1531\u201344.","journal-title":"Lancet"},{"issue":"4","key":"2258_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S2213-8587(21)00049-8","volume":"9","author":"ED Rossi","year":"2021","unstructured":"Rossi ED, Pantanowitz L, Hornick JL. A worldwide journey of thyroid cancer incidence centred on tumour histology. Lancet Diabetes Endocrinol. 2021;9(4):193\u20134.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2258_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1015798","volume":"13","author":"Y Li","year":"2022","unstructured":"Li Y, Rao M, Zheng C, Huang J, Fang D, Xiong Y, et al. Analysis of factors influencing the clinical outcome after surgery and 131I therapy in patients with moderate-risk thyroid papillary carcinoma. Front Endocrinol (Lausanne). 2022;13:1015798.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2258_CR5","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1007\/s00259-020-05020-5","volume":"48","author":"A Piccardo","year":"2021","unstructured":"Piccardo A, Siri G, Raffa S, Castellana M, Foppiani L, Bottoni G, et al. How to better stratify the risk of differentiated thyroid carcinomas: the key role of radioactive iodine therapy, age, and gender. Eur J Nucl Med Mol Imaging. 2021;48(3):822\u201330.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2258_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00640","volume":"8","author":"C Wang","year":"2018","unstructured":"Wang C, Diao H, Ren P, Wang X, Wang Y, Zhao W. Efficacy and affecting factors of 131I thyroid remnant ablation after surgical treatment of differentiated thyroid carcinoma. Front Oncol. 2018;8:640.","journal-title":"Front Oncol"},{"issue":"1","key":"2258_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/hed.24550","volume":"39","author":"M Prpic","year":"2017","unstructured":"Prpic M, Kust D, Kruljac I, Kirigin LS, Jukic T, Dabelic N, et al. Prediction of radioactive iodine remnant ablation failure in patients with differentiated thyroid cancer: a cohort study of 740 patients. Head Neck. 2017;39(1):109\u201315.","journal-title":"Head Neck"},{"issue":"11","key":"2258_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e20853","volume":"9","author":"XY Wu","year":"2023","unstructured":"Wu XY, Li B, Zhang J, Duan LL, Hu BX, Gao YJ. Analysis of the clinical factors affecting excellent response of Iodine-131 treatment for pulmonary metastases from differentiated thyroid cancer. Heliyon. 2023;9(11):e20853.","journal-title":"Heliyon"},{"issue":"38","key":"2258_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000044540","volume":"104","author":"LTT Nhung","year":"2025","unstructured":"Nhung LTT, Hoan NX, Giang DP, Dung DT, Phuong NT, Hanh NTM, et al. Prognostic significance of BRAF V600E and TERT promoter mutations in radioiodine resistance and recurrence of differentiated thyroid cancer. Medicine (Baltimore). 2025;104(38):e44540.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"2258_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.14639\/0392-100X-N3029","volume":"44","author":"O B\u00fclb\u00fcl","year":"2024","unstructured":"B\u00fclb\u00fcl O, Nak D. Predicting excellent response to radioiodine in differentiated thyroid cancer using machine learning. Acta Otorhinolaryngol Ital. 2024;44(4):261\u20138.","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"1","key":"2258_CR11","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1186\/s12885-024-12146-4","volume":"24","author":"H Wang","year":"2024","unstructured":"Wang H, Zhang C, Li Q, Tian T, Huang R, Qiu J, et al. Development and validation of prediction models for papillary thyroid cancer structural recurrence using machine learning approaches. BMC Cancer. 2024;24(1):427.","journal-title":"BMC Cancer"},{"issue":"3","key":"2258_CR12","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s12020-023-03625-y","volume":"84","author":"R Wen","year":"2024","unstructured":"Wen R, Zhao M, Chen C, Yang Y, Zhang B. A novel nomogram integrated with preablation stimulated thyroglobulin and thyroglobulin\/thyroid-stimulating hormone ratio to predict the therapeutic response of intermediate- and high-risk differentiated thyroid cancer patients: a bi-center retrospective study. Endocrine. 2024;84(3):989\u201398.","journal-title":"Endocrine"},{"key":"2258_CR13","doi-asserted-by":"crossref","unstructured":"Xue Y, Zheng M, Wu X, Li B, Ding X, Liu S, et al. A digital pathology model for predicting radioiodine-avid metastases on initial post-therapeutic 131I scan in patients with papillary thyroid cancer. Sci Rep. 2024;14(1):26786.","DOI":"10.1038\/s41598-024-78459-3"},{"issue":"1","key":"2258_CR14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s42256-019-0138-9","volume":"2","author":"SM Lundberg","year":"2020","unstructured":"Lundberg SM, Erion G, Chen H, DeGrave A, Prutkin JM, Nair B, et al. From local explanations to global understanding with explainable AI for trees. Nat Mach Intell. 2020;2(1):56\u201367.","journal-title":"Nat Mach Intell"},{"issue":"1","key":"2258_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1\u2013133.","journal-title":"Thyroid"},{"key":"2258_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2021.106295","volume":"208","author":"Q Chen","year":"2021","unstructured":"Chen Q, Huang J, Salehi HS, Zhu H, Lian L, Lai X, et al. Hierarchical CNN-based occlusal surface morphology analysis for classifying posterior tooth type using augmented images from 3D dental surface models. Comput Methods Programs Biomed. 2021;208:106295.","journal-title":"Comput Methods Programs Biomed"},{"key":"2258_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2019.101811","volume":"23","author":"JP Kim","year":"2019","unstructured":"Kim JP, Kim J, Park YH, Park SB, Lee JS, Yoo S, et al. Machine learning based hierarchical classification of frontotemporal dementia and Alzheimer\u2019s disease. Neuroimage Clin. 2019;23:101811.","journal-title":"Neuroimage Clin"},{"key":"2258_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2022.107672","volume":"98","author":"HB Kibria","year":"2022","unstructured":"Kibria HB, Matin A. The severity prediction of the binary and multi-class cardiovascular disease - A machine learning-based fusion approach. Comput Biol Chem. 2022;98:107672.","journal-title":"Comput Biol Chem"},{"issue":"10","key":"2258_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1012544","volume":"20","author":"Y Zuo","year":"2024","unstructured":"Zuo Y, Fang X, Wan J, He W, Liu X, Zeng X, et al. PreMLS: The undersampling technique based on ClusterCentroids to predict multiple lysine sites. PLoS Comput Biol. 2024;20(10):e1012544.","journal-title":"PLoS Comput Biol"},{"issue":"13","key":"2258_CR20","doi-asserted-by":"publisher","first-page":"11073","DOI":"10.1007\/s00432-023-04998-3","volume":"149","author":"T Ma","year":"2023","unstructured":"Ma T, Shi P, Ma T, Liang M, Wang L, Shi Y. Nomogram to predict the risk of biochemical recurrence and structural recurrence in patients with stage cN1 papillary thyroid carcinoma. J Cancer Res Clin Oncol. 2023;149(13):11073\u201383.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"2258_CR21","first-page":"518","volume":"57","author":"M Prpi\u0107","year":"2018","unstructured":"Prpi\u0107 M, Franceschi M, Romi\u0107 M, Juki\u0107 T, Kusi\u0107 Z. Thyroglobulin as a tumor marker in differentiated thyroid cancer - clinical considerations. Acta Clin Croat. 2018;57(3):518\u201327.","journal-title":"Acta Clin Croat"},{"issue":"1","key":"2258_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.surg.2019.06.048","volume":"167","author":"J Jayasekara","year":"2020","unstructured":"Jayasekara J, Jonker P, Lin JF, Engelsman AF, Wong MS, Kruijff S, et al. Early postoperative stimulated serum thyroglobulin quantifies risk of recurrence in papillary thyroid cancer. Surgery. 2020;167(1):40\u20135.","journal-title":"Surgery"},{"issue":"8","key":"2258_CR23","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1515\/CCLM.2005.142","volume":"43","author":"L Giovanella","year":"2005","unstructured":"Giovanella L, Ceriani L, Ghelfo A, Keller F. Thyroglobulin assay 4 weeks after thyroidectomy predicts outcome in low-risk papillary thyroid carcinoma. Clin Chem Lab Med. 2005;43(8):843\u20137.","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"2258_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/RLU.0b013e318266d4d8","volume":"38","author":"A Piccardo","year":"2013","unstructured":"Piccardo A, Arecco F, Puntoni M, Foppiani L, Cabria M, Corvisieri S, et al. Focus on high-risk DTC patients: high postoperative serum thyroglobulin level is a strong predictor of disease persistence and is associated to progression-free survival and overall survival. Clin Nucl Med. 2013;38(1):18\u201324.","journal-title":"Clin Nucl Med"},{"issue":"11","key":"2258_CR25","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1089\/thy.2019.0368","volume":"30","author":"ZJO Lee","year":"2020","unstructured":"Lee ZJO, Eslick GD, Edirimanne S. Investigating antithyroglobulin antibody as a prognostic marker for differentiated thyroid cancer: a meta-analysis and systematic review. Thyroid. 2020;30(11):1601\u201312.","journal-title":"Thyroid"},{"issue":"9","key":"2258_CR26","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1210\/jc.2017-00286","volume":"102","author":"AJ Wassner","year":"2017","unstructured":"Wassner AJ, Della Vecchia M, Jarolim P, Feldman HA, Huang SA. Prevalence and significance of thyroglobulin antibodies in pediatric thyroid cancer. J Clin Endocrinol Metab. 2017;102(9):3146\u201353.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2258_CR27","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4158\/EP10123.OR","volume":"17","author":"G Azizi","year":"2011","unstructured":"Azizi G, Malchoff CD. Autoimmune thyroid disease: a risk factor for thyroid cancer. Endocr Pract. 2011;17(2):201\u20139.","journal-title":"Endocr Pract"},{"issue":"4","key":"2258_CR28","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1089\/thy.2015.0445","volume":"26","author":"PW Rosario","year":"2016","unstructured":"Rosario PW, Carvalho M, Mour\u00e3o GF, Calsolari MR. Comparison of antithyroglobulin antibody concentrations before and after ablation with 131I as a predictor of structural disease in differentiated thyroid carcinoma patients with undetectable basal thyroglobulin and negative neck ultrasonography. Thyroid. 2016;26(4):525\u201331.","journal-title":"Thyroid"},{"issue":"14","key":"2258_CR29","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1001\/jama.2013.3190","volume":"309","author":"M Xing","year":"2013","unstructured":"Xing M, Alzahrani AS, Carson KA, Viola D, Elisei R, Bendlova B, et al. Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. JAMA. 2013;309(14):1493\u2013501.","journal-title":"JAMA"},{"issue":"6","key":"2258_CR30","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.surg.2012.08.039","volume":"152","author":"JD Prescott","year":"2012","unstructured":"Prescott JD, Sadow PM, Hodin RA, Le LP, Gaz RD, Randolph GW, et al. BRAF V600E status adds incremental value to current risk classification systems in predicting papillary thyroid carcinoma recurrence. Surgery. 2012;152(6):984\u201390.","journal-title":"Surgery"},{"key":"2258_CR31","doi-asserted-by":"crossref","unstructured":"Brumfield A, Azar SA, Nordgren R, Cohen RN, Sarne D, Keutgen XM, et al. Prevalence and clinical impact of BRAF p.V600E mutation in papillary thyroid carcinoma. Endocr Pathol. 2025;36(1):13.","DOI":"10.1007\/s12022-025-09859-y"},{"issue":"1","key":"2258_CR32","first-page":"793","volume":"8","author":"J Lu","year":"2015","unstructured":"Lu J, Gao J, Zhang J, Sun J, Wu H, Shi X, et al. Association between BRAF V600E mutation and regional lymph node metastasis in papillary thyroid carcinoma. Int J Clin Exp Pathol. 2015;8(1):793\u20139.","journal-title":"Int J Clin Exp Pathol"},{"key":"2258_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1071775","volume":"13","author":"L P\u00e9rez-Fern\u00e1ndez","year":"2022","unstructured":"P\u00e9rez-Fern\u00e1ndez L, Sastre J, Zaf\u00f3n C, Oleaga A, Castelblanco E, Capel I, et al. Validation of dynamic risk stratification and impact of BRAF in risk assessment of thyroid cancer, a nation-wide multicenter study. Front Endocrinol (Lausanne). 2022;13:1071775.","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02258-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-026-02258-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02258-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:02:02Z","timestamp":1792522922000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-026-02258-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["2258"],"URL":"https:\/\/doi.org\/10.1007\/s12149-026-02258-1","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the First Affiliated Hospital of Chongqing Medical University (2025\u2013542-01). Informed consent was waived by the ethics committee on the grounds that all data were anonymized.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}]}}